Christopher Maag

Christopher Maag is currently the Director of R&D Quality Assurance at Endo Pharmaceuticals. Prior to this role, Christopher held the position of Manager, Global Clinical Quality Assurance at Teva Pharmaceuticals. With a Master's Degree in Regulatory Affairs and Quality Assurance and a background in Biology, Christopher has extensive experience in conducting GCP site audits, managing FDA and Health Canada inspection preparedness, and recording clinical product complaints. Christopher is skilled in identifying and reporting possible serious breaches of GCP and protocol in clinical trials.